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Abstract
Background: Arthroplasty is a proven treatment option for glenohumeral osteoarthritis. Common indications
include primary or posttraumatic osteoarthritis, avascular necrosis of the humeral head, rotator cuff tear arthropathy
and rheumatoid osteoarthritis. Arthroplasty is rarely performed among patients with glenohumeral dysmelia. An
overuse of the upper limb in patients with thalidomide-induced phocomelia and people with similar congenital
deformities like dysmelia results in premature wear of the shoulder joint. This study aims to evaluate our experience
with cases of glenohumeral osteoarthritis caused by dysmelia and treated with arthroplasty. To date, few reports on
the outcome of shoulder arthroplasty exist on this particular patient group.
Case presentation: We included four dysmelic patients (five shoulders) with substantial glenoid dysplasia in a
prospective database after approval by the local ethics committee. Once conservative treatment options had been
exhausted, the patients were treated with shoulder arthroplasty and assessed clinically and radiographically before
and after surgery. The mean patient age at the time of surgery was 50.4 years. The minimum follow-up time was
24 months (24–91 months). All patients experienced a considerable improvement of range of motion (ROM) and a
relief of pain. No intra- or postoperative complications appeared.
Conclusion: Patients with dysmelia have acceptable short and mid-term results with resurfacing hemiarthroplasty.
It is an effective although somewhat complicated method to relieve pain and improve movement. Long-term
performance of arthroplasty in patients with dysmelia remains to be seen, particularly with regard to the remaining
problem of the altered and often deficient glenoid.
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Background
The cases of people with thalidomide induced phoco-
melia serve as an example as 2012 was the 50th anniver-
sary of one of the most tragic occurrences in the history
of modern medicine. Today the victims of thalidomide
have grown up and suffer from severe physical problems.
Their average age now is between 52 and 57 years. Grad-
ually, restriction of mobility and increasing pain result in
a diminished quality of life of the affected young people
[1, 2]. The combination of several factors promote the
development of osteoarthritis, as life expectancy has in-
creased in this population. Anatomical anomaly of the
upper limbs affects the bony anatomy of the proximal
humerus as well as the glenoid as defined by dysplasia
and the glenohumeral articular surface. Furthermore, it
affects the soft tissue by means of the glenohumeral liga-
ments and capsule, the muscles themselves and their in-
sertions. Overloading and overstressing lead to severe
premature failure of the affected joints. Patients suffer
from a reduced functional ROM, limb contractures and
increasing pain, which lead to limited mobility and a loss
of function in activities of daily routine. Patients develop
alternative movements in order to remain independent
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of other people’s help and carry on tasks of daily living.
Limited mobility of adjacent joints leads to extreme stresses
on the shoulder joint, which attempts to compensate this
disability. Despite intensive physical therapy, long-term
sequelae have increased in our patients in recent years.
The primary aim of this study was to evaluate our ex-
perience with cases of glenohumeral osteoarthritis
caused by dysmelia and treated with arthroplasty. Only a
few articles report on the development of osteoarthritis
in patients with glenoid dysplasia [3–5]. Our patient
series showed similar signs of physical impairment and
psychological distress. When the patients initially visited
our clinic, the primary symptoms were increasing shoul-
der pain and a restricted ROM. Despite exploiting all
conservative therapy options, joint function deteriorated,
and pain increased over several years, leading to severe
impairment necessitating invasive therapeutic measures.
Thalidomide-induced phocomelia
Some 10.000–12.000 children in more than 46 countries all
over the world were estimated to have been born with
severe physical disabilities until 1962, a result of the
sleep-inducing drug thalidomide, if it had been taken
in the first trimester of pregnancy [6–8]. Thalidomide-
induced embryopathy results in malformation of various
degrees. The exact teratogenic mechanism of thalidomide
causing limb malformations remains unclear [9, 10]. Chil-
dren had abnormally short limbs, to some extent they
showed an absence of the proximal portion of limbs and
the distal parts being attached to the trunk - a condition
which is known as phocomelia, which is more common in
the upper extremities.
Literature supports our clinical impression that there
is a growing need for information as the thalidomide vic-
tims are getting older and their problems in everyday life
increase every day [2, 7]. The Department of Gerontol-
ogy at the University of Heidelberg has recently evalu-
ated 900 questionnaires of 2380 contacted thalidomide
victims. It becomes apparent that one third of the re-
spondents are already afflicted with recently diagnosed
acquired osteoarthrosis of the shoulder, 58 % are
afflicted with shoulder aches and about 40 % are suffer-
ing from a myasthenia or muscle hardening of the upper
limbs. There is a significant increase of all disorders
compared to results obtained 5 years ago [11].
Case presentation
Patients
This study investigates a consecutive series of four dysme-
lia patients who underwent shoulder arthroplasty at the
University of Heidelberg. All clinical and radiographic data
from these patients were evaluated retrospectively.
Three patients suffered from thalidomide-induced phoco-
melia. In one patient dysmelia occurred without a known
cause. All patients suffered from increasing shoulder pain
and a restricted ROM due to osteoarthritis and underwent
arthroplasty in our hospital. All conservative therapy
options had been exhausted. An arthrodesis was not con-
sidered an acceptable solution. Regular development of the
shoulder and upper limbs was never observed. Additionally
three patients showed pronounced ankylosis at the elbow
and wrist joints. Excessive wear of the glenohumeral joint
was observed in all patients. The wear process led to signifi-
cant pain and impaired mobility, which even led to incap-
acity to work and provide for oneself and a diminished
quality of life. Limitations extended over several years and
the usual conservative measures were taken to delay the
progression of the disease. Patients reported having had a
long period of suffering. Humeral head resurfacing pros-
theses were used in all cases but one, in which a stemless
prosthesis was used. All patients agreed with the publica-
tion of their clinical course (Ethics committee vote: S-305/
2007, Ethikkommission Medizinische Fakultät Heidelberg).
The subjects were assessed clinically before and after sur-
gery quantifying their ROM and the pain on the visual ana-
log scale (VAS). ROM was quantified with a goniometer.
Preoperative diagnostics
Standard radiological diagnostics include conventional
x-ray images: true anterior-posterior (AP) view (Fig. 1a)
and axial view (Fig. 1b).
The dysplastic glenoid cavity appeared irregularly shaped.
The humeral heads were deformed and flattened in this
region. An assessment of regional anatomy was limited by
severe defects of the shoulder joint and necessitated per-
forming computed tomography (CT) (Fig. 2a and b).
Surgical technique and implants
The operation was performed in beach chair position
under general anaesthesia through the standard anterior
deltopectoral approach using the technique described by
Neer [12]. If the long biceps tendon was present, a ten-
otomy in addition to extensive capsular tissue release
was performed. Of note, none of these patients had a
well-defined rotator cuff, but all had a substantial joint
capsule constriction and adhesion to surrounding struc-
tures. Peripheral osteophytes were removed from the hu-
meral head in order to enable the necessary dislocation.
The status of the rotator cuff, the humeral head and the
glenoid cavity were used to determine the final implant.
Medialization of the glenohumeral joint and an Outer-
bridge chondromalacia grade III to IV was noted in all
patients [13]. Only one patient showed an intact glenoid
socket suitable for attachment of a glenoid component
(Aequalis Glenoid medium, Tornier Inc., Edina, MN,
USA, Case 4, Fig. 5). A correct central placement was
targeted. Reaming was performed without opening the
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cancellous bone. An individualized glenoid component
was not necessary. All other patients received hemi-
arthroplasty due to a combination of substantial bone
stock defect and dysplastic development and misalign-
ment of the glenoid, making reconstruction impossible.
Cup prostheses were used in all cases but one, in
which an anatomic prosthesis (Simpliciti®, Tornier Inc.,
Edina, MN, USA) was used (Case 3, Fig. 3). Aequalis®
Resurfacing Head (Tornier Inc., Edina, MN, USA) was
used twice (Cases 1 and 2). One case was treated with
an Epoca RH Cup (Argomedical®, Cham, Switzerland)
and a glenoid component (Aequalis®, Tornier Inc., Edina,
MN, USA; Case 4). When using the resurfacing pros-
thesis, the humeral head was measured and a central
guide pin was placed through the favoured axis before
preparing the head with hemispherical reamers. The
cement-free prostheses were impacted in press-fit tech-
nique in a slight valgus position. Before implanting the
anatomic prosthesis an anatomical neck resection was
performed. The centre of the head was located and a
low profile collar was inserted before the definitive head
was implanted. After implantation, the anterior capsule
and the presumed subscapularis tendon were repaired
using non-absorbable sutures.
Postoperative rehabilitation
After surgery the arm was immediately placed in a splint
(Tricodur® Gilchrist plus, BSN medical, Hamburg,
Germany) for 2 weeks and all patients underwent a
standard protocol for physical therapy with a rehabilita-
tion programme. Active and passive exercises were lim-
ited to 90° as to abduction and flexion. External rotation
was prohibited postoperatively for 4 weeks. After that
time, free active and passive movement was allowed
without any limitation.
Statistical analysis
The statistical analysis was done with SPSS 20.0 software
(IBM SPSS Statistics, Munich, Germany).
Fig. 1 a and b: Preoperative true AP and axial view of the left shoulder show the displacement of the joint and hypoplasia of the glenoid. X-rays
reveal a small, irregularly shaped bone (Case 3). Poor ROM prevents optimal visualization of the bone stock and the glenoid surface
Fig. 2 a and b: The cross-sectional pictures of the shoulder demonstrate the preoperative wear of all parts of the glenohumeral joint with a
hypoplastic glenoid (Case 3). A large inferior socket defect can be seen. (a - coronal plane. b - axial plane)
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Usually a non-parametric test like the Wilcoxon rank
sum test should be used for a small number of cases. From
other studies it is well known that these parameters are
normally distributed in the population, so we decided to
use the t-test as it has better discriminatory power. The
paired t test was used to compare the preoperative and
postoperative scores. Mean values and the standard devia-




The findings of the preoperative and postoperative clin-
ical examinations are shown in the following graphs and
Tables 1, 2 and 3.
All patients benefited from almost complete remission
of pain and significant improvement of ROM. Only Cases
3 and 4 reported occasional pain of the shoulder, particu-
larly in terminal motions. None of the patients required
reoperation. No other intraoperative or postoperative
complications like wound infection, hematoma or neuro-
logical deficiencies occurred (Fig. 4).
Furthermore, the Constant score was calculated [8].
The mean Constant score improved from 11.2 points
(7 to 20 points) preoperatively to 78.4 points (54 to 88
points) postoperatively. Flexion and abduction were
significantly higher. Significant differences were also
found in external and internal rotation.
Radiological outcome
Radiographical signs of implant loosening (radiolucent
lines around the humeral implants or osteolysis) were
not found in our group. Neither radiolucent lines nor
signs of loosening were found around the glenoid
component in Case 4. Neither malposition nor hu-
meral head dislocation was noted. In our thalidomide
patients, the humeral head was concentrically reduced
in the deficient glenoid. No signs of emerging glenoid
erosion or wear were found in postoperative x-rays.
No heterotopic ossification was found. No intra- or
Fig. 3 a and b: Postoperative pictures as an example for a patient (Case 3) without glenoid component of due to substantial bone stock defect
(true AP and axial view of the left shoulder)
Table 1 Individual preoperative findings
Patient [No./side] Age at time of arthroplasty [years] ROM VAS
Flexion [°] Abduction [°] External rotation [°] Internal rotation [region]a
1 right 47 30 30 0 gluteal muscle 8/10
1 left 48 90 90 30 sacrum 7/10
2 left 50 40 60 −10 lateral thigh 6/10
3 left 51 20 35 −45 lateral thigh 8/10
4 left 58 20 90 10 lateral thigh 8/10
aInternal rotation was graded according to the posterior spinal region that could be reached by the thumb
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postoperative complications appeared. None of the pa-
tients required reoperation (Fig. 5a and b).
Discussion
Arthroplasty for patients with dysmelia
Patients with glenohumeral joint dysplasia have limited
treatment options. Smaller, altered anatomy and fibrosis
of the capsule and ligaments make surgery extraordinar-
ily difficult. In addition, the treatment must adapt to the
requirements of life and delay the progression of the dis-
ease. Arthrodesis of the shoulder would reduce pain.
However, in combination with coexistent ankylosis of
the elbow or wrist joint, it results in a total loss of func-
tionality of the limb. Arthroplasty with stemmed or re-
verse shoulder prosthesis is not an adequate procedure
for patients with glenohumeral joint dysplasia. New con-
cepts for anatomical reconstruction have been developed
over the years to restore anatomy without loss of the hu-
meral bone stock [14–16]. Humeral resurfacing arthro-
plasty can be an alternative to conventional arthroplasty.
Resurfacing arthroplasty entails less invasive surgery,
shorter operation times, little to no risk of periprosthetic
stem fractures or loosening of the glenoid component
and preservation of bone stock without loss of humerus
length. This allows for easier revision surgery, if neces-
sary. Meanwhile, humeral head resurfacing prostheses
have been used in many shoulder diseases including pri-
mary and posttraumatic osteoarthritis, avascular necrosis,
rheumatoid arthritis and cuff-tear arthropathy. These indi-
cations have proven useful in younger patients [17, 18], but
are not suitable for advanced necrosis or deformation of
the humeral head [19]. Due to anatomic anomalies - most
notably dysplasia of the glenoid and no well-defined rotator
cuff - a total shoulder prosthesis could not be implanted.
Anchoring a glenoid component, either anatomical or re-
verse, was not feasible due to the lack of glenoid bone
stock. In addition, it was not possible to use bone-sparing
glenoid components as suggested by Sears et al. or to re-
construct the socket of the glenoid in all three thalidomide
patients [20]. Consequently, the patients received hemiar-
throplasties. In order to expose the anatomic neck of the
proximal humerus and to excavate humeral head osteo-
phytes, an improvement of external rotation using a suffi-
cient soft tissue release was performed. The decisive
argument for resurfacing arthroplasty is the possibility of
having the free choice of retroversion as well as inclination
angle. The lack of surgical landmarks requires substantial
experience to avoid imprecise positioning of the prosthesis
and improper soft tissue balancing. The difficulty in achiev-
ing arthroplasty stability is to perform a balancing act in
the management of the bone and soft tissue in dysmelic
patients.
Arthroplasty among patients with glenohumeral dysmelia
is a rarely performed surgery, and as a result no long-term
results are available. Only one source, Newman et al.,
reported a case of a 35-year-old woman with thalidomide-
induced phocomelia. In 1999 he had predicted a rise of de-
generative joint diseases in this population [21]. Duralde et
al. reported on two cases with Apert’s Syndrome and Erb’s
palsy treated with resurfacing prostheses [22]. ROM did
not change significantly at follow-up, but arthroplasty re-
sulted in high patient satisfaction and excellent pain relief.
Table 2 Individual postoperative findings
Patient [No./side] Follow-up [months] ROM VAS
Flexion [°] Abduction [°] External rotation [°] Internal rotation [region]a
1 right 60 140 120 55 L2 0/10
1 left 49 140 120 45 L3 0/10
2 left 32 160 130 10 L5 0/10
3 left 24 110 90 15 gluteal muscle 3/10
4 left 91 170 170 25 gluteal muscle 1/10
aInternal rotation was graded according to the posterior spinal region that could be reached by the thumb
Table 3 Preoperative and postoperative findings
Preoperativea Postoperativea p value**
Constant score (points) 11.2 ± 5.3 (7 to 20) 78.4 ± 13,8 (54 to 88) .0006
VAS (points) 7.4 ± 0.9 (6 to 8) 0.8 ± 1.3 (0 to 3) .0002
Flexion (deg) 40.0 ± 29.2 (20 to 90) 144.0 ± 23.0 (110 to 170) .0033
Abduction (deg) 61.0 ± 28.8 (30 to 90) 126.0 ± 28.8 (90 to 170) .0034
External rotation (deg) −3.0 ± 27.7 (−45 to 30) 30.0 ± 19.4 (10 to 55) .0306
Internal rotation (deg) −53.0 ± 17.2 (−80 to −40) −76.0 ± 8.9 (−80 to −60) .0402
**Preoperative compared with postoperative. The level of significance was set at p < 0.05
aThe values are given as the mean and the standard deviation, with the range in parentheses
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Mansat et al. treated 4 patients with not otherwise specified
dysmelia using cup prostheses without glenoid resurfacing,
even in cases of eccentric glenoid wear. They reported, that
the worst results were obtained for rheumatoid arthritis
and dysplasia (Constant 60 points; follow-up 33.7 months;
mean age 62 years). A pain score of 11.8 points was re-
ported according to Constant criteria of 15 points [23]. This
correlates with our patient series, which reported a mean
pain of 13 points according to Constant criteria. Smith et
al. reported on three cases of hemiarthroplasty with
stemmed prostheses in a series of twelve patients with pri-
mary glenoid dysplasia [24]. The mean age at onset of
symptoms was 50 years with mean pain ratings on the
visual analogue score of 5 out of 10 postoperatively. The
follow-up time was not described. Due to of the lack of
glenoid bone stock, inserting a glenoid component would
have been difficult and the results were described as rela-
tively disappointing compared with standard procedures.
The premature development of osteoarthritis in patients
with primary dysplasia of the glenoid has been described in
the literature [25, 26]. Allen et al. reported an update to the
series by Sperling et al. [3]. They treated 22 shoulders with
glenoid dysplasia and secondary osteoarthritis using eight
hemiarthroplasties. The authors recommended that glenoid
deficiency and cartilage wear should be addressed at the
time of shoulder arthroplasty in patients with glenoid
Fig. 4 a and b: Clinical examination shows excellent ROM despite ankylosis of the elbow at follow-up (Case 4 - left shoulder)
Fig. 5 a and b show total shoulder arthroplasty (Case 4) at follow-up (true AP and axial view of the left shoulder)
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dysplasia and glenoid problems necessitating revision sur-
gery were frequent. Our experience would confirm this.
We performed glenoid replacement in only one case in
which a bone stock of the glenoid was suited to accept a
glenoid component. Both Smith et al. and Allen et al. re-
ported on a specific disease limited to the glenoid, in con-
trast to our series where the surrounding soft tissue was
also involved [24, 27].
Sewell et al. [5] described a series of 13 shoulders in
10 patients. Five unconstrained TSAs, 4 linked (con-
strained) TSAs, and 4 HAs (2 stemmed and 2 resur-
facing implants) were implanted. He was able to prove
that arthroplasty provides the ability to improve pain
and function and concluded that shoulder arthroplasty is
a viable treatment option in patients with skeletal dys-
plasia. He explained that their high revision rate of 31 %
was due to multiple pathologic joint processes compared
to the general population.
A limitation of this study is the low incidence of dis-
ease, resulting in the small sample size, and making a
randomized controlled setup unfeasible. The particular
and varied shoulder anatomy of the individual patients is
the reason for the heterogeneity of the prosthetic selec-
tion, which we feel is necessary to offer the patient the
best treatment.
Conclusion
This patient series indicates that shoulder arthroplasty is a
feasible treatment option for patients with dysmelia who
develop osteoarthritis of the shoulder. Short to midterm re-
sults support the procedure of humeral head resurfacing.
Resurfacing and stemless shoulder arthroplasty seem to be
a promising option to treat non-anatomical conditions, es-
pecially if conservative measures have been exhausted and
arthrodesis is not desired. A considerable improvement of
ROM and pain reduction was achieved in all patients. Prior
to surgery the expectations of an operation and personal
demand must be clarified because arthroplasty cannot be-
come a substitute for emerging impaired mobility, im-
proper use or mechanical overstressing. However, long-
term performance of arthroplasty in patients with dysmelia
remains to be seen.
Consent
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